Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIN1 | Q13526 | 5/20 | 0.58 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.47 |
| ▸ | IDO1 | P14902 | 2/20 | 0.43 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.43 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.43 |
| ▸ | ACP3 | P15309 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4515757 | 0.89 | HTT (0.49) | PIN1IDO1CRBNTSHRHTT | |
| SCHEMBL4830828 | 0.84 | PIN1 (0.62) | PIN1KCNQ2IDO1PDPK1CRBN | |
| SCHEMBL12431131 | 0.82 | PIN1 (0.60) | PIN1KCNQ2IDO1PDPK1ACP3 | |
| SCHEMBL907688 | 0.82 | PIN1 (0.60) | PIN1KCNQ2IDO1PDPK1ACP3 | |
| SCHEMBL1567245 | 0.82 | PIN1 (0.60) | PIN1KCNQ2IDO1PDPK1CRBN | |
| SCHEMBL2790690 | 0.82 | PIN1 (0.60) | PIN1KCNQ2IDO1PDPK1ACP3 | |
| SCHEMBL1400973 | 0.82 | PIN1 (0.60) | PIN1KCNQ2IDO1PDPK1ACP3 | |
| SCHEMBL643577 | 0.81 | PIN1 (0.58) | PIN1KCNQ2IDO1PDPK1CRBN | |
| SCHEMBL8848989 | 0.81 | PIN1 (0.58) | PIN1KCNQ2IDO1PDPK1CRBN | |
| SCHEMBL2475968 | 0.81 | PIN1 (0.58) | PIN1KCNQ2IDO1PDPK1CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0280275-B1 | N-INDANYL CARBOXAMIDE DERIVATIVE AND AGRICULTURAL/HORTICULTURAL FUNGICIDE CONTAINING THE DERIVATIVE AS ACTIVE INGREDIENT | MITSUBISHI KASEI CORPORATION (JP) | 1992-04-29 | — | — | EP | claimed |
| US-4308380-A | 2-Lower alkyl-2 or 3-cephem-4-carboxylic acid derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-12-29 | — | — | US | claimed |
| JP-1313402-A | — | — | None | — | — | JP | disclosed |
| JP-2000175-A | — | — | None | — | — | JP | disclosed |
| JP-62249966-A | — | — | None | — | — | JP | disclosed |
| JP-2157266-A | — | — | None | — | — | JP | disclosed |
| JP-10072398-A | — | — | None | — | — | JP | disclosed |
| EP-4574815-A1 | PROCESS FOR THE SEPARATION OF AROMATIC SULPHONIC ACIDS AND SALTS FROM AQUEOUS PHASES | Saltigo GmbH (DE) | 2025-06-25 | — | — | EP | disclosed |
| WO-2014121036-A1 | 5-DEUTERO-2,4-THIAZOLIDINEDIONE AND 5-DEUTERO-2,4-OXAZOLIDINEDIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | DEUTERX, LLC (US) | 2014-08-07 | — | — | WO | disclosed |
| US-20140221369-A1 | 5-DEUTERO-2,4-THIAZOLIDINEDIONE AND 5-DEUTERO-2,4-OXAZOLIDINEDIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | DEUTERX, LLC (US) | 2014-08-07 | — | — | US | disclosed |
| US-7199139-B2 | Medicinal compositions containing diuretic and insulin resistance-improving agent | SANKYO COMPANY, LIMITED (JP) | 2007-04-03 | — | — | US | disclosed |
| US-6432993-B1 | BENZIMIDAZOLE OR IMIDAZO(4,5-B)PYRIDINE DERIVATES; IMMUNOMODULATORS; ALDOSE REDUCTASE AND LIPOXYGENASE INHIBITORS; DIABETES; PREVENTS LIPID PEROXIDATION; ANTILIPEMIC, HYPOTENSIVE AGENTS | SANKYO COMPANY, LIMITED (JP) | 2002-08-13 | — | — | US | disclosed |
| EP-1167366-A1 | AMINE DERIVATIVES | Sankyo Company, Limited (JP) | 2002-01-02 | — | — | EP | disclosed |
| EP-1167357-A1 | ALPHA-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES | Sankyo Company, Limited (JP) | 2002-01-02 | — | — | EP | disclosed |
| EP-1022272-A1 | SUBSTITUTED FUSED HETEROCYCLIC COMPOUNDS | Sankyo Company Limited (JP) | 2000-07-26 | — | — | EP | disclosed |
| JP-H1072398-A | PRODUCTION OF 1-INDANONE | ICHIKAWA GOSEI KAGAKU KK | 1998-03-17 | — | — | JP | disclosed |
| JP-H02157266-A | N-INDANYLCARBOXYLIC ACID AMIDE DERIVATIVE AND GERMICIDE FOR AGRICULTURE AND HORTICULTURE CONTAINING THE SAME AS ACTIVE INGREDIENT | MITSUBISHI KASEI CORP | 1990-06-18 | — | — | JP | disclosed |
| JP-H02175-A | N-INDANYLCARBOXYLIC ACID AMIDE DERIVATIVE AND AGRICULTURAL AND HORTICULTURAL FUNGICIDE CONTAINING THE SAME DERIVATIVE AS ACTIVE COMPONENT | MITSUBISHI KASEI CORP | 1990-01-05 | — | — | JP | disclosed |
| JP-H01313402-A | CONTROLLER OF GRAY MOLD COMPRISING N-INDANYLCARBOXYLIC ACID AMIDE CATALYST AS ACTIVE INGREDIENT | MITSUBISHI KASEI CORP | 1989-12-18 | — | — | JP | disclosed |
| JP-S62249966-A | N-INDANYLAMIDE DERIVATIVE AND FUNGICIDE CONTAINING SAME AS ACTIVE INGREDIENT | SUMITOMO CHEM CO LTD | 1987-10-30 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140221369-A1 | 5-DEUTERO-2,4-THIAZOLIDINEDIONE AND 5-DEUTERO-2,4-OXAZOLIDINEDIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | SRD5A2, PPARD, SRD5A1 | PIN1 993/4885KCNQ2 1559/4885IDO1 562/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.